Stocks Health care PHVS
NASDAQ · Health carePharvaris N.V. (PHVS)
It posted a net loss of $26M. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 2, 2026.
What Pharvaris N.V. does
Pharvaris N.V. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PHVS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2020 | n/a | -$26M | n/a | n/a |
| 2020 | n/a | -$8M | n/a | n/a |
| 2018 | n/a | -$4.3M | n/a | n/a |
Latest SEC filings
What Pharvaris N.V. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- September 8, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- June 26, 2026
- June 11, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 12, 2026
- May 11, 2026
Questions about PHVS
What does Pharvaris N.V. do?
Pharvaris N.V. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PHVS.
Is Pharvaris N.V. profitable?
No. In fiscal 2020 it reported a net loss of $26M.
When did Pharvaris N.V. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 2, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade from September 25, 2026.
Similar companies
Follow PHVS
Get an email when Pharvaris N.V. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PHVS: get an email when it filesWhere the numbers come from
Financial figures are the values Pharvaris N.V. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.